Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia

Oral Oncology

Volumn 46, Issue 2, 2010, Pages 123-127

  Schaaij Visser, Tieneke B M ^a,b   Bremmer, Jantine F ^c   Braakhuis, Boudewijn J M ^c   Heck, Albert J R ^a,b   Slijper, Monique ^a,b   van der Waal, Isaäc ^d   Brakenhoff, Ruud H ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dysplasia grading; Oral leukoplakia; Prediction of malignant progression; Protein biomarkers

Indexed keywords

CYTOKERATIN 13; CYTOKERATIN 4; TUMOR MARKER; TUMOR MARKER CORNULIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-13; KERATIN-4; LEUKOPLAKIA, ORAL; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 74649086854     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.11.012     Document Type: Article

References (30)

1. Warnakulasuriya S., Johnson N.W., and van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36 (2007) 575-580
2. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 (2002) 195-215
3. Lee J.J., Hong W.K., Hittelman W.N., Mao L., Lotan R., Shin D.M., et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 6 (2000) 1702-1710
4. Schepman K.P., van der Meij E.H., Smeele L.E., and van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34 (1998) 270-275
5. Brennan M., Migliorati C.A., Lockhart P.B., Wray D., Al-Hashimi I., Axell T., et al. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl. S19 (2007) e1-e12
6. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45 (2009) 317-323
7. Lodi G., Sardella A., Bez C., Demarosi F., and Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev (2006) CD001829
8. Braakhuis B.J., Leemans C.R., and Brakenhoff R.H. A genetic progression model of oral cancer: current evidence and clinical implications. J Oral Pathol Med 33 (2004) 317-322
9. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 (1996) 2488-2492
10. Ha P.K., Chang S.S., Glazer C.A., Califano J.A., and Sidransky D. Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol 45 (2009) 335-339
11. Mao L., Lee J.S., Fan Y.H., Ro J.Y., Batsakis J.G., Lippman S., et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2 (1996) 682-685
12. Rosin M.P., Lam W.L., Poh C., Le N.D., Li R.J., Zeng T., et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 62 (2002) 6447-6450
13. Partridge M., Pateromichelakis S., Phillips E., Emilion G.G., A'Hern R.P., and Langdon J.D. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 60 (2000) 3893-3898
14. Kainuma K., Katsuno S., Hashimoto S., Oguchi T., Suzuki N., Asamura K., et al. Differences in the expression of genes between normal tissue and squamous cell carcinomas of head and neck using cancer-related gene cDNA microarray. Acta Otolaryngol 126 (2006) 967-974
15. Baker H., Patel V., Molinolo A.A., Shillitoe E.J., Ensley J.F., Yoo G.H., et al. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol 41 (2005) 183-199
16. Matta A., DeSouza L.V., Shukla N.K., Gupta S.D., Ralhan R., and Siu K.W. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 7 (2008) 2078-2087
17. Ohkura S., Kondoh N., Hada A., Arai M., Yamazaki Y., Sindoh M., et al. Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 41 (2005) 607-613
18. Patel V., Hood B.L., Molinolo A.A., Lee N.H., Conrads T.P., Braisted J.C., et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 14 (2008) 1002-1014
19. Ralhan R., Desouza L.V., Matta A., Chandra Tripathi S., Ghanny S., Datta Gupta S., et al. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 7 (2008) 1162-1173
20. Ralhan R., Desouza L.V., Matta A., Chandra Tripathi S., Ghanny S., Dattagupta S., et al. iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res 8 (2009) 300-309
21. Roesch-Ely M., Nees M., Karsai S., Magele I., Bogumil R., Vorderwulbecke S., et al. Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur J Cell Biol 84 (2005) 431-444
22. Roesch-Ely M., Nees M., Karsai S., Ruess A., Bogumil R., Warnken U., et al. Proteomic analysis reveals successive aberrations in protein expression from healthy mucosa to invasive head and neck cancer. Oncogene 26 (2007) 54-64
23. Imai F.L., Uzawa K., Nimura Y., Moriya T., Imai M.A., Shiiba M., et al. Chromosome 1 open reading frame 10 (C1orf10) gene is frequently down-regulated and inhibits cell proliferation in oral squamous cell carcinoma. Int J Biochem Cell Biol 37 (2005) 1641-1655
24. Schaaij-Visser TB, Graveland AP, Gauci S, Braakhuis BJ, Buijze M, Heck AJ, et al. Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas Clin Cancer Res in press.
25. Kramer I.R., Lucas R.B., Pindborg J.J., and Sobin L.H. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46 (1978) 518-539
26. Van Hal N.L., Van Dongen G.A., Rood-Knippels E.M., Van Der Valk P., Snow G.B., and Brakenhoff R.H. Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform. Int J Cancer 68 (1996) 520-527
27. Van Hal N.L., Van Dongen G.A., Ten Brink C.B., Herron J.N., Snow G.B., and Brakenhoff R.H. Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitope. Cancer Immunol Immunother 45 (1997) 88-92
28. Xu Z., Wang M.R., Xu X., Cai Y., Han Y.L., Wu K.M., et al. Novel human esophagus-specific gene c1orf10: cDNA cloning, gene structure, and frequent loss of expression in esophageal cancer. Genomics 69 (2000) 322-330
29. Yagui-Beltran A., Craig A.L., Lawrie L., Thompson D., Pospisilova S., Johnston D., et al. The human oesophageal squamous epithelium exhibits a novel type of heat shock protein response. Eur J Biochem 268 (2001) 5343-5355
30. Holmstrup P., Vedtofte P., Reibel J., and Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol 42 (2006) 461-474